Impact of metabolic syndrome components on clinical outcomes in hypertriglyceridemia-induced acute pancreatitis

Table 4 Relationship between metabolic syndrome and clinical outcomes in hypertriglyceridemia-acute pancreatitis

Outcome parameter	Group
	Non-metabolic syndrome		Low-component metabolic Syndrome		High-component metabolic syndrome
	OR (95%CI)	P value	OR (95%CI)	P value	OR (95%CI)	P value
Pleural effusion	Reference	-	2.16 (1.13-4.14)	0.019a	3.43 (1.73-6.80)	< 0.001a
Peritoneal effusion	Reference	-	2.27 (1.04-4.92)	0.039a	3.78 (1.72-8.34)	0.001a
Localized complications	Reference	-	2.14 (1.11-4.13)	0.023a	3.63 (1.73-7.65)	0.001a
APFC	Reference	-	1.61 (0.73-3.55)	0.240	2.09 (0.94-4.65)	0.071
ANC	Reference	-	0.99 (0.52-1.93)	0.992	1.64 (0.84-3.20)	0.149
PPC	Reference	-	1.10 (0.33-3.62)	0.876	0.72 (0.18-2.89)	0.638
Systemic complications	Reference	-	2.67 (1.38-5.16)	0.004a	6.49 (3.17-13.30)	< 0.001a
Respiratory failure	Reference	-	3.24 (1.03-10.16)	0.044a	9.32 (3.07-28.25)	< 0.001a
Renal failure	Reference	-	1.54 (0.55-4.30)	0.414	3.02 (1.12-8.11)	0.028a
Circulatory failure	Reference	-	2.86 (0.56-14.73)	0.207	3.14 (0.60-16.26)	0.173
SIRS	Reference		2.54 (1.30-4.93)	0.006a	4.54 (2.25-9.14)	< 0.001a
SAP	Reference	-	1.88 (0.74-4.82)	0.187	5.05 (2.04-12.49)	< 0.001a
ICU admission	Reference	-	2.25 (0.83-6.13)	0.112	6.41 (2.42-16.97)	< 0.001a

^aP < 0.05.

OR: Odds ratio; APFC: Acute peripancreatic fluid collection; ANC: Acute necrotic collection; PPC: Pancreatic pseudocyst; SIRS: Systemic inflammatory response syndrome; SAP: Severe acute pancreatitis; ICU: Intensive care unit.